Thomas Mandrup-Poulsen

A guiding map for inflammation

Richard Hotchkiss, Michael T Heneka, Alberto Mantovani, 2017, Nature Immunology.

Recent advances: Diabetes

T. Mandrup-Poulsen, Thomas Mandrup-Poulsen, 1998 .

Blockade of interleukin 1 in type 1 diabetes mellitus

M. Donath, T. Mandrup-Poulsen, Thomas Mandrup-Poulsen, 2010, Nature Reviews Endocrinology.

Apoptotic signal transduction pathways in diabetes.

T. Mandrup-Poulsen, Thomas Mandrup-Poulsen, 2003, Biochemical pharmacology.

Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes

Kathrin Maedler, M. Donath, K. Maedler, 2003, Journal of Molecular Medicine.

(19)F-heptuloses as tools for the non-invasive imaging of GLUT2-expressing cells.

Tom Dresselaers, Karim Louchami, Uwe Himmelreich, 2012, Archives of biochemistry and biophysics.

Interleukin-1-receptor antagonist in type 2 diabetes mellitus.

Allan Vaag, Burkhardt Seifert, A. Vaag, 2007, The New England journal of medicine.

Histone Deacetylase (HDAC) Inhibition as a Novel Treatment for Diabetes Mellitus

N. Billestrup, T. Mandrup-Poulsen, Thomas Mandrup-Poulsen, 2011, Molecular medicine.

Poor pregnancy outcome in women with type 2 diabetes.

Tine D Clausen, P. Damm, T. Mandrup-Poulsen, 2005, Diabetes care.